Press Release

Lucerno praised Congress for enacting the first ‘minibus’ appropriations, which includes critical provisions pushing the U.S. Nuclear Regulatory Commission (NRC) and Veterans Health Administration (VHA) to improve quality, safety, and transparency of nuclear medicine services. Press Release

Lucerno announced the worldwide first use of Lara^® Real-Time Visualization (RTV) in a clinical setting at Carilion Roanoke Memorial Hospital, Carilion Clinic’s flagship facility. Press Release

Lucerno praised both the U.S. House of Representatives and the U.S. Senate for passing legislation that includes important provisions regarding a patient safety issue that affects thousands of patients every year and pushing the U.S. Nuclear Regulatory Commission (NRC) and Veterans Health Administration (VHA) to put patients first. Press Release

Lucerno informed the US Nuclear Regulatory Commission (NRC) that a key document used to develop the patient injury reporting criterion did not meet NRC’s requirements for information quality. Asks NRC to immediately issue Interim Staff Guidance. Press Release

U.S. Nuclear Regulatory Commission accepts Lucerno’s petition for rulemaking and directs the commencement of a rulemaking process to close an outdated loophole in nuclear medicine safety regulations. Press Release

Lucerno announces Fiscal Year 2022 Omnibus Appropriations Act preserves critical language to protect the safety of nuclear medicine patients and enhance transparency within the American healthcare system. Then attach the press release below for full text. Press Release

Lucerno has entered into a Master Resellers Agreement to add its Lara^® System to the Siemens Healthineers portfolio of medical imaging products. With this agreement, Siemens Healthineers becomes Lucerno’s first United States partner reseller and makes the Lara^® System available to nuclear medicine customers nationwide. Press Release

Lucerno highlighted a peer-reviewed publication in the radiation safety journal Health Physics demonstrating that extravasations of routinely-used radiopharmaceuticals can cause unintended irradiation to patient tissue that “exceed well-established radiation protection and regulatory limits.” Press Release

Lucerno announced that Fiscal Year 2021 bills advanced this week by the House Appropriations Committee to the House floor include critical language to protect the safety of nuclear medicine patients and enhance transparency within the American healthcare system. Press Release

Lucerno submitted a formal petition for rulemaking to the U.S. Nuclear Regulatory Commission, which calls on the agency to update a 1980 policy that allows nuclear medicine injection errors to remain hidden from patients, treating physicians, and NRC itself. Press Release

The Organization of Agreement States (OAS) – 39 states that work with the U.S. Nuclear Regulatory Commission (NRC) to regulate medical use of radioactive material – has called on NRC to update a 1980 policy that allows nuclear medicine injection errors (extravasations) to remain hidden from patients, treating physicians, and NRC itself. Press Release

Quality of Resulting PET/CT Image Depends on Center and Technologist Performing Radiopharmaceutical Injection. Press Release